04 June 2019
: Case report 
A Case Report of Atezolizumab Induced Tumor Lysis Syndrome
Unusual clinical course, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Unexpected drug reaction, Clinical situation which can not be reproduced for ethical reasons
Faisal Fa’ak1BCDEF, Diego Vanegas1BCDEF, Kofi M. Osei1ABDEFG*DOI: 10.12659/AJCR.915351
Am J Case Rep 2019; 20:785-789
Related articles
16 Sep 2020 : Case report
Tumor Lysis Syndrome After a Single Dose of Atezolizumab with Nab-Paclitaxel: A Case Report and Review of Literature
Xavier Carrier, Sumit Gaur
DOI: 10.12659/AJCR.925248
Am J Case Rep 2020; 21:e925248
16 Feb 2019 : Clinical Research
Association Between Activation of the Programmed Cell Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Pathway and Pain in Patients with Cancer
Jian Zhang, Huali Zhang
DOI: 10.12659/MSM.912632
Med Sci Monit 2019; 25:1275-1282
03 Feb 2019 : Case report
A Rare Case of Spontaneous Tumor Lysis Syndrome in Idiopathic Primary Myelofibrosis
Yong Sub Na, Sang-Gon Park
DOI: 10.12659/AJCR.912682
Am J Case Rep 2019; 20:146-150
06 Mar 2019 : Case report
Uncommon Presentation of Metastatic Squamous Cell Carcinoma of the Skin and Treatment Challenges
Anita Pandey, Maksim Liaukovich
DOI: 10.12659/AJCR.913488
Am J Case Rep 2019; 20:294-299
29 Nov 2019 : Case report
Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia: A Rare Case Report from Nephrology
Zaher Armaly, Mazen Elias
DOI: 10.12659/AJCR.917211
Am J Case Rep 2019; 20:1776-1780
11 Jul 2018 : Animal Research
Endotoxin Tolerant Dendritic Cells Suppress Inflammatory Responses in Splenocytes via Interleukin-1 Receptor Associated Kinase (IRAK)-M and Programmed Death-Ligand 1 (PDL-1)
Yuping Zhou, Qin Xia
DOI: 10.12659/MSM.908242
Med Sci Monit 2018; 24: ANS4798-4806
28 Sep 2018 : Clinical Research
Correlation of T Cell Immunoglobulin and ITIM Domain (TIGIT) and Programmed Death 1 (PD-1) with Clinicopathological Characteristics of Renal Cell Carcinoma May Indicate Potential Targets for Treatment
Xin Hong, Xiaofeng Wang
DOI: 10.12659/MSM.910388
Med Sci Monit 2018; 24: CLR6861-6872
03 Jul 2018 : Laboratory Research
Programmed Death Receptor 1 (PD1) Knockout and Human Telomerase Reverse Transcriptase (hTERT) Transduction Can Enhance Persistence and Antitumor Efficacy of Cytokine-Induced Killer Cells Against Hepatocellular Carcinoma
Kanghua Huang, Bowen Sun
DOI: 10.12659/MSM.910903
Med Sci Monit 2018; 24: LBR4573-4582
27 Oct 2016 : Animal Research
Induction of Patient-Derived Xenograft Formation and Clinical Significance of Programmed Cell Death Ligand 1 (PD-L1) in Lung Cancer Patients
Yuanyuan Ma, Panpan Zhang
DOI: 10.12659/MSM.900661
Med Sci Monit 2016; 22:4017-4025
03 Sep 2015 : Case report
Rasburicase-Induced Methemoglobinemia in a Patient with Aggressive Non-Hodgkin’s Lymphoma
Mohammed A. Alessa, Ann Kathryn Craig
DOI: 10.12659/AJCR.894088
Am J Case Rep 2015; 16:590-593
In Press
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.946727
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.946839
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.946674
Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.945853
Most Viewed Current Articles
21 Jun 2024 : Case report
96,276
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
52,197
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
20 Nov 2023 : Case report 
31,128
DOI :10.12659/AJCR.941424
Am J Case Rep 2023; 24:e941424
18 Feb 2024 : Case report
23,383
DOI :10.12659/AJCR.943030
Am J Case Rep 2024; 25:e943030